It's clear that many do not understand what @NIH-funded research does to improve health. It's time to revive a study published 10 years ago that provides incredible information about this. link in the comment
Every single new drug approved by the FDA from 2010–2016 was built on NIH-funded research—that’s all 210 drugs. But what the public sees is just the tip of the iceberg.
Pharma takes credit for the final product, but beneath each drug developed, there are ~20 years of basic research, and 90% of the cost is from basic research funded by the NIH, which discovers drug targets, understands disease mechanisms, and creates life-saving treatments.
Figuring out how cancer evades the immune system, how addiction rewires the brain, and how heart disease develops is the role of the NIH, creating the foundation for the breakthrough drugs that come 20 years later, and the NIH does all that with only 0.8% of the US budget.
Without NIH, there would be no cancer immunotherapy, no anti-overdose medication, no anti-heart attack or stroke medication, no cutting-edge treatments.
If NIH funding is cut, the iceberg will melt. That means fewer cures, more suffering, and more lives lost.
The science beneath the surface keeps us afloat.
Invest in NIH. Invest in life
This preprint allows for “explanation” of the ion forms using khipu ore annotation and conclude that the dark matter are mostly real compounds - still dark. They find less than 10% ISFs. In the end ISF prevalence is dependent on instrument tuning, type/amt of analyte, matrix, etc
#MANA2024 is still on next week in Tampa! Lots of hard work from the organizing committee to make it all happen. Check out our #Bruker lunch seminar with @karibbasso focusing on #lipidomics sample normalization.
https://t.co/yfKsvmOlgT
🎉 Gary Siuzdak (@kadzuis) has been named on The Power List 2024! As Professor and Director at the Scripps Research for Metabolomics and Mass Spectrometry, his pioneering work is advancing the field in remarkable ways. #TeamMassSpec
Congrats!
https://t.co/MHw9HW7mYL
Join Bruker's lunch seminar at IMSC to hear about addressing challenges in developing spatial multi-omics strategies and an advanced multi-platform approach for the structural elucidation of novel endogenous metabolites.
https://t.co/yU9E6Ex5Wh
#maldiimaging#Metabolomics
As mentioned some time ago, there is an opening for a mass spec specialist (post-doc) working between our lab and the metabolomics facility @CECAD_ to support the Bioanalytical Platform of @CRC1218, https://t.co/xTXWxXwnfK
Send your applications here: https://t.co/X0YFGQHifv
Save the date for IMSC 2024 in August 17-23 in Melbourne, Australia! Visit Bruker at booth A to learn about our latest Mass Spectrometry technologies and solutions and find details about our lunch seminars: https://t.co/k2Ze2j4gCx
#MassSpectrometry#maldiimaging#Proteomics
Next up is QA/QC, an imperative part of any metabolomics experimental design. Excited to hear Dajana Vuckovic discuss semi quantitation in #lipidomics at #MetSoc2024